Beovu and Pantoprazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Beovu (brolucizumab-dbll) and Pantoprazole (pantoprazole sodium). Common drug interactions include retinal vasculitis among females and diplopia among males.

The phase IV clinical study analyzes what interactions people have when they take Beovu and Pantoprazole. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Beovu?

Beovu has active ingredients of brolucizumab-dbll. eHealthMe is studying from 3,872 Beovu users. Check the latest studies of Beovu.

What is Pantoprazole?

Pantoprazole has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 285,165 Pantoprazole users. Check the latest studies of Pantoprazole.

On Jul, 14, 2026

16 people who take Beovu and Pantoprazole together, and have interactions are studied.

Beovu and Pantoprazole drug interactions.

What are the common drug interactions of Beovu and Pantoprazole, by gender? *:

female:

Retinal vasculitis (a sight-threatening inflammatory eye condition that involves the retinal vessels)
Ocular vasculitis (inflammation eye blood vessels)
Optic disc disorder (disease of optic disc of eye)
Intraocular pressure increased
Eye inflammation
Episcleritis (acute inflammatory disorder of the episclera of eye)
Eye pain
Scleritis (inflammation of sclera)
Visual impairment
Visual acuity reduced (reduced clearness of vision)

male:

Diplopia (double vision)
Retinal degeneration (death of the cells of the retina)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Prostate cancer
Retinal artery occlusion (blockage of retinal artery)
Retinal tear
Vision blurred
Vitreous detachment (a condition of the eye in which the vitreous humour separates from the retina)
Vitreous floaters (spots before the eyes)
Vitritis (inflammation of the vitreous humour of the eye)

What are the common drug interactions of Beovu and Pantoprazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Retinal vasculitis (a sight-threatening inflammatory eye condition that involves the retinal vessels)
Ocular vasculitis (inflammation eye blood vessels)
Retinal artery occlusion (blockage of retinal artery)
Endophthalmitis (inflammation of the internal coats of the eye)
Ocular hyperaemia (an abnormally large amount of blood in eye)
Photophobia (extreme sensitivity to light)
Vision blurred
Visual acuity reduced (reduced clearness of vision)
Vitreous opacities (vitreous opacities generally develop as aging changes within the eye)
Blindness

What are the existing conditions these people have? *

High Blood Pressure: 6 people, 37.50%
Choroidal Neovascularisation (creation of new blood vessels in vascular layer of eye): 4 people, 25.00%
Age-Related Macular Degeneration: 4 people, 25.00%
Pain: 3 people, 18.75%
Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 3 people, 18.75%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 18.75%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 3 people, 18.75%
Parkinson's Disease: 3 people, 18.75%
Urination - Painful: 3 people, 18.75%
Ocular Discomfort (a generic expression when there is lack of ease in/about the eyes): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Beovu and Pantoprazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously